Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03804502 · ClinicalTrials.gov registry record · NA
Pilot Study of TearCare System - Long-Term Extension
A NA study, sponsored by Sight Sciences.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT03804502 is a NA study that has completed, run by Sight Sciences. The registered enrollment target is 12 participants.
The verdict
NCT03804502, a NA study, has completed, sponsored by Sight Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
The objective of the study is to evaluate the long-term clinical utility, safety, and effectiveness of re-treatment with the TearCare™ System in adult patients with dry eye syndrome who had previously been treated with the TearCare System.
Interventions
- DEVICE TearCare
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2018-12-17 |
| Est. Completion | 2019-05-21 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03804502
The ClinicalTrials.gov registry entry for NCT03804502 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sight Sciences, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which TearCare is the first listed.
NCT03804502 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03804502 about?
NCT03804502 is a clinical study titled "Pilot Study of TearCare System - Long-Term Extension". The objective of the study is to evaluate the long-term clinical utility, safety, and effectiveness of re-treatment with the TearCare™ System in adult patients with dry eye syndrome who had previously been treated with the TearCare System.
What is the current status of trial NCT03804502?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2018-12-17. Estimated completion is 2019-05-21.
What interventions are being tested in trial NCT03804502?
The interventions under investigation include: TearCare (DEVICE).
Who is sponsoring clinical trial NCT03804502?
This trial is sponsored by Sight Sciences, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.